Alan F. Holmer - 26 Jan 2024 Form 4 Insider Report for Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Role
Director
Signature
/s/ Alan Holmer
Issuer symbol
CRBP
Transactions as of
26 Jan 2024
Net transactions value
$0
Form type
4
Filing time
30 Jan 2024, 18:07:21 UTC
Previous filing
22 May 2023
Next filing
20 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRBP Common Stock Options Exercise $3,126 +629 +84% $4.97 1,379 26 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRBP Options to purchase common stock Options Exercise $3,126 -629 -100% $4.97 0 26 Jan 2024 Common stock 629 $4.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option vested in equal monthly installments over a period of 12 months commencing on February 28, 2014.